Vaughan David Investments LLC Pfizer Inc Transaction History

Vaughan David Investments LLC

$4.35 Billion
Q3 2024

A detailed history of Vaughan David Investments LLC transactions in Pfizer Inc stock. As of the latest transaction made, Vaughan David Investments LLC holds 12,493 shares of PFE stock, worth $327,816. This represents 0.01% of its overall portfolio holdings.

Number of Shares

12,493

Previous 13,381 6.64%

Holding current value

$327,816

Previous $374,000 3.21%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $24,597 - $27,874	-888 Reduced 6.64%	12,493 $362,000
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $17,656 - $20,690	-699 Reduced 4.96%	13,381 $374,000
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $12,297 - $14,121	-475 Reduced 3.26%	14,080 $391,000
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $186,228 - $241,890	-7,127 Reduced 32.87%	14,555 $419,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $35,010 - $40,923	-1,091 Reduced 4.79%	21,682 $719,000
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $29,437 - $34,058	-815 Reduced 3.46%	22,773 $835,000
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $69,287 - $90,201	-1,759 Reduced 6.94%	23,588 $962,000
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $12,483 - $16,295	299 Added 1.19%	25,347 $1.3 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $9,320 - $11,378	-213 Reduced 0.84%	25,048 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $14,005 - $16,606	-301 Reduced 1.18%	25,261 $1.32 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $231,815 - $287,248	-5,067 Reduced 16.54%	25,562 $1.32 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $189,906 - $281,505	4,596 Added 17.65%	30,629 $1.81 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $129,328 - $166,133	-3,295 Reduced 11.23%	26,033 $1.12 Million
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $257,043 - $291,187	-7,158 Reduced 19.62%	29,328 $1.15 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $1.07 Million - $1.21 Million	-32,030 Reduced 46.75%	36,486 $1.32 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $396,853 - $504,633	-11,857 Reduced 14.75%	68,516 $2.52 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $285,464 - $334,914	-8,991 Reduced 10.06%	80,373 $2.95 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $462,251 - $560,779	-15,347 Reduced 14.66%	89,364 $2.92 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $16.5 Million - $23.6 Million	-611,844 Reduced 85.39%	104,711 $3.42 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $260,989 - $296,190	-7,928 Reduced 1.09%	716,555 $28.1 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $58,546 - $75,918	1,802 Added 0.25%	724,483 $26 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $124,215 - $139,465	-3,359 Reduced 0.46%	722,681 $31.3 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $30,225 - $33,207	806 Added 0.11%	726,040 $30.8 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $1.82 Million - $2.08 Million	-47,409 Reduced 6.14%	725,234 $31.7 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $630,042 - $764,203	-18,278 Reduced 2.31%	772,643 $34.1 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $216,513 - $230,825	6,565 Added 0.84%	790,921 $28.7 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $307,357 - $356,576	9,632 Added 1.24%	784,356 $27.8 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $626,917 - $665,181	18,849 Added 2.49%	774,724 $28.1 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $23.2 Million - $25.6 Million	748,303 Added 9882.5%	755,875 $27 Million
Q3 2017 Nov 08, 2017	SELL	$31.0 - $34.15 $23.4 Million - $25.7 Million	-753,348 Reduced 99.0%	7,572 $694,000
Q2 2017 Aug 14, 2017	BUY	N/A	760,920	760,920 $25.6 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Account

Vaughan David Investments LLC Pfizer Inc Transaction History